Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice

被引:166
|
作者
Stewart, Gavin B. [1 ]
Altman, Douglas G. [2 ]
Askie, Lisa M. [3 ]
Duley, Lelia [4 ]
Simmonds, Mark C. [1 ]
Stewart, Lesley A. [1 ]
机构
[1] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England
[2] Univ Oxford, Ctr Stat Med, Oxford, England
[3] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia
[4] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham NG7 2RD, England
来源
PLOS ONE | 2012年 / 7卷 / 10期
关键词
PATIENT DATA METAANALYSIS; RANDOMIZED-TRIALS; META-REGRESSION; LEVEL; MODEL; HETEROGENEITY; TIME;
D O I
10.1371/journal.pone.0046042
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Individual participant data (IPD) meta-analyses that obtain "raw'' data from studies rather than summary data typically adopt a "two-stage'' approach to analysis whereby IPD within trials generate summary measures, which are combined using standard meta-analytical methods. Recently, a range of "one-stage'' approaches which combine all individual participant data in a single meta-analysis have been suggested as providing a more powerful and flexible approach. However, they are more complex to implement and require statistical support. This study uses a dataset to compare "two-stage'' and "one-stage'' models of varying complexity, to ascertain whether results obtained from the approaches differ in a clinically meaningful way. Methods and Findings: We included data from 24 randomised controlled trials, evaluating antiplatelet agents, for the prevention of pre-eclampsia in pregnancy. We performed two-stage and one-stage IPD meta-analyses to estimate overall treatment effect and to explore potential treatment interactions whereby particular types of women and their babies might benefit differentially from receiving antiplatelets. Two-stage and one-stage approaches gave similar results, showing a benefit of using anti-platelets (Relative risk 0.90, 95% CI 0.84 to 0.97). Neither approach suggested that any particular type of women benefited more or less from antiplatelets. There were no material differences in results between different types of one-stage model. Conclusions: For these data, two-stage and one-stage approaches to analysis produce similar results. Although one-stage models offer a flexible environment for exploring model structure and are useful where across study patterns relating to types of participant, intervention and outcome mask similar relationships within trials, the additional insights provided by their usage may not outweigh the costs of statistical support for routine application in syntheses of randomised controlled trials. Researchers considering undertaking an IPD meta-analysis should not necessarily be deterred by a perceived need for sophisticated statistical methods when combining information from large randomised trials.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Psychosocial factors and the incidence of breast cancer: two-stage individual participant data meta-analyses
    Van Tuijl, L.
    Basten, M.
    Pan, K. Y.
    De Graeff, A.
    Dekker, J.
    Hoogendoorn, A.
    Lamers, F.
    Geerlings, M.
    Vermeulen, R.
    Voogd, A.
    Rosmalen, J.
    Ranchor, A.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S6 - S7
  • [42] Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses
    Koopman, Laura
    van der Heijden, Geert J. M. G.
    Hoes, Arno W.
    Grobbee, Diederick E.
    Rovers, Maroeska M.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (03) : 358 - 361
  • [43] A comparison of analytic approaches for individual patient data meta-analyses with binary outcomes
    Doneal Thomas
    Robert Platt
    Andrea Benedetti
    BMC Medical Research Methodology, 17
  • [44] A comparison of the results of checked versus unchecked individual patient data meta-analyses
    Burdett, S
    Stewart, LA
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 619 - 624
  • [45] A comparison of analytic approaches for individual patient data meta-analyses with binary outcomes
    Thomas, Doneal
    Platt, Robert
    Benedetti, Andrea
    BMC MEDICAL RESEARCH METHODOLOGY, 2017, 17 : 1 - 12
  • [46] Compliance With Preferred Reporting Items for Systematic Review and Meta-Analysis Individual Participant Data Statement for Meta-Analyses Published for Stroke Studies
    Jumah, Fareed
    Chotai, Silky
    Ashraf, Omar
    Rallo, Michael S.
    Raju, Bharath
    Gadhiya, Arjun
    Sun, Hai
    Narayan, Vinayak
    Gupta, Gaurav
    Nanda, Anil
    STROKE, 2021, 52 (09) : 2817 - 2826
  • [47] Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data
    Shi, Xiaoting
    Zhuo, Haoran
    Du, Yuxuan
    Nyhan, Kate
    Ioannidis, John
    Wallach, Joshua D.
    BMJ MEDICINE, 2022, 1 (01):
  • [48] Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey
    Ahmed, Ikhlaaq
    Sutton, Alexander J.
    Riley, Richard D.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [49] Is there bias in the publication of individual patient data meta-analyses?
    Tierney, JF
    Clarke, M
    Stewart, LA
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (02) : 657 - 667
  • [50] A rationale for the meta-analyses (overviews) on individual patient data
    Gueyffier, F
    Boutitie, F
    Cucherat, M
    Boissel, JP
    EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 31 - 36